Submissions are currently open for the second-annual Christopher Doheny Award, sponsored by the New York City–based Center for Fiction and Audible, Inc. The award is given for a book-length manuscript of fiction or creative nonfiction on the topic of serious physical illness. The award includes a $10,000 prize, along with publication and promotion of the book in print and audio editions.
Works by "a writer who has personally dealt or is dealing with life-threatening illness, either his or her own or that of a close relative or friend" are eligible. Writers must have previously published in literary journals or magazines, or have had a book published by an independent or traditional publisher. Previously unpublished manuscripts of any length written in English are eligible. Both adult and young adult works will be considered.
Writers should submit a manuscript along with a bibliography of published books, articles, or stories; a paragraph-long bio and contact information; if submitting an unfinished manuscript, a book proposal for the work being submitted and two sample chapters; if submitting a finished manuscript, a synopsis of up to two pages with the full manuscript. Submissions should be sent by e-mail to firstname.lastname@example.org or by mail to the Christopher Doheny Award, Center for Fiction, 17 E. 47th Street, New York, NY 10017. The deadline is October 30. Visit the website for complete guidelines.
A panel of three distinguished writers and two representatives of Audible, Inc. will judge.
The winner of the 2013 award was Michelle Bailat-Jones for her novel Fog Island Mountains, forthcoming in November, about a South African expatriate living in a small town in Japan who faces a terminal cancer diagnosis. For those in New York City, Bailat-Jones will appear at the Center for Fiction on November 6 to discuss her novel.
The annual is named in honor of Christopher Doheny, who was diagnosed with cystic fibrosis when he was an infant and worked for Audible, Inc. for eight years. He passed away in February 2013.